Share
Journal Information
Issue
Vol. 9. Issue S1.Pages S7-S140 (January 2010)
Introduction
The Latin American Association for the Study of the Liver in its Meeting on Diagnosis, Management and Treatment of Hepatitis C
Nahum Méndez-Sánchez
Ann Hepatol. 2010;9 Supl 1:S7
Open access
Special article
Latin American Association for the Study of the Liver Practice Guidelines
Nahum Méndez-Sánchez, Adrian Gadano, Angelo Alves de Mattos, Alejandro Soza, Augusto Marroni Claudio, Marcela Galoppo, David Kershenobich, Edna Strauss, ... Hugo Cheinquer
Ann Hepatol. 2010;9 Supl 1:S8-S26
Open access
Module i
Epidemiology of HCV infection in Latin America
Nahum Méndez-Sánchez, Ylse Gutiérrez-Grobe, Ramón Arturo Kobashi-Margáin
Ann Hepatol. 2010;9 Supl 1:S27-9
Open access
Module ii
Routes of transmission of hepatitis C virus
Alejandro Soza, Arnoldo Riquelme, Marco Arrese
Ann Hepatol. 2010;9 Supl 1:S30-3
Open access
Module iiimodule iii
Diagnosis of patients with suspected chronic hepatitis C infection
Adrián Gadano, Omar Galdame, Sebastián Marciano
Ann Hepatol. 2010;9 Supl 1:S34-8
Open access
Module iv
Usefulness of liver biopsy in chronic hepatitis C
Edna Strauss
Ann Hepatol. 2010;9 Supl 1:S39-42
Open access
Module v
Noninvasive markers of liver fibrosis in Latin America and Mexico
Misael Uribe, Ylse Gutiérrez-Grobe, Ramón Arturo Kobashi-Margáin, Nahum Méndez-Sánchez
Ann Hepatol. 2010;9 Supl 1:S43-8
Open access
Module vi
Indications for treatment in chronic HCV infection
Milagros Dávalos Moscol
Ann Hepatol. 2010;9 Supl 1:S49-53
Open access
Module vii
Predictors of response to chronic hepatitis C treatment
Henrique Sergio Moraes Coelho, Cristiane Alves Villela-Nogueira
Ann Hepatol. 2010;9 Supl 1:S54-60
Open access
Module viii
Characteristics of hepatitis C treatment with pegylated interferons and ribavirin
Ricardo Jiménez-Méndez, Gilberto Castañeda-Hernández
Ann Hepatol. 2010;9 Supl 1:S61-4
Open access
Module ix
Chronic hepatitis C treatment in näive patients
Jorge Daruich
Ann Hepatol. 2010;9 Supl 1:S65-71
Open access
Module x
Clinical aproach to the patient with chronic hepatitis C infection and normal aminotransferases
Rodrigo Zapata
Ann Hepatol. 2010;9 Supl 1:S72-9
Open access
Module xi
Treatment of HCV infection in patients with cirrhosis
Angelo Alves de Mattos, Ângelo Zambam de Mattos
Ann Hepatol. 2010;9 Supl 1:S80-3
Open access
Module xii
Treatment of recurrent hepatitis C post-liver transplantation
Claudio Augusto Marroni
Ann Hepatol. 2010;9 Supl 1:S84-91
Open access
Module xiii
The management of HCV-infected pregnant women
Guillermo Valladares, Maria H. Sjogren, Alfonso Chacaltana
Ann Hepatol. 2010;9 Supl 1:S92-7
Open access
Module xiv
Management of hepatitis C virus infection in childhood
Marcela Galoppo, Cristina Galoppo
Ann Hepatol. 2010;9 Supl 1:S98-S102
Open access
Module xv
Treatment of HCV infected patients and renal disease
David Kershenobich
Ann Hepatol. 2010;9 Supl 1:S103-6
Open access
Module xvi
Acute hepatitis C treatment
Paulo Roberto Lerias de Almeida
Ann Hepatol. 2010;9 Supl 1:S107-11
Open access
Module xvii
Insulin resistance, hepatic steatosis and hepatitis C: A complex relationship with relevant clinical implications
Marco Arrese, Arnoldo Riquelme, Alejandro Soza
Ann Hepatol. 2010;9 Supl 1:S112-8
Open access
Module xviii
Hepatitis C and hepatocellular carcinoma
Eduardo Fassio
Ann Hepatol. 2010;9 Supl 1:S119-22
Open access
Module xix
On the cusp of change: New therapeutic modalities for HCV
Maribel Rodríguez-Torres
Ann Hepatol. 2010;9 Supl 1:S123-31
Open access
Module xx
Hepatitis C virus infection in health-care settings: Medical and ethical implications
Francisco Javier Bosques-Padilla, Genaro Vázquez-Elizondo, Ana Villaseñor-Todd, Elvira Garza-González, José Alberto Gonzalez-Gonzalez, Héctor Jesús Maldonado-Garza
Ann Hepatol. 2010;9 Supl 1:S132-40
Open access
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
